US-based company that provides laboratory equipment for drug development, cell and gene therapy research and academic research Caron Products and Services, Inc. announced on Wednesday that it has named Joanna Moncivaiz as its new president and CEO.
Moncivaiz is to replace Jay Hexamer, who has announced his retirement. Hexamer is to continue to serve the firm in a senior advisory role.
Moncivaiz has earlier served as CFO and VP of Finance at Filtec and VP of Finance at TASI Group. She has more than 20 years of experience building profitable global platforms in the test, measurement, and instrumentation sectors by implementing business systems, reducing complexity in workflows, and focusing on quality.
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business
Insmed receives highest ranking in Science's 2024 Top Employers Survey
OncoZenge partners with Pharmanovia for exclusive BupiZenge commercialization in EMENA regions
Viatris added to Forbes' World's Best Employers 2024 list
Rarity Health named finalist for 21st MM+M Rare Disease Agency of the Year
AxoSim names new vice president of Sales and Marketing
Kyverna Therapeutics names new CEO and board member
Anervea.ai names new chief commercial officer and board member